Prospera Financial Services Inc Amgen Inc Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Amgen Inc stock. As of the latest transaction made, Prospera Financial Services Inc holds 30,373 shares of AMGN stock, worth $8 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

30,373

Previous 23,711 28.1%

Holding current value

$8 Million

Previous $7.41 Million 32.1%

% of portfolio

0.26%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $2.06 Million - $2.25 Million	6,662 Added 28.1%	30,373 $9.79 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $808,219 - $982,197	-3,076 Reduced 11.48%	23,711 $7.41 Million
Q1 2024 Aug 13, 2024	BUY	$268.87 - $324.56 $706,052 - $852,294	2,626 Added 11.08%	26,337 $7.49 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $130,662 - $147,403	511 Added 1.94%	26,787 $7.72 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $111,511 - $138,444	-510 Reduced 1.9%	26,276 $7.06 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $275,122 - $325,327	1,284 Added 5.03%	26,786 $5.95 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $2.51 Million - $3.06 Million	11,105 Added 77.13%	25,502 $6.17 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $1.56 Million - $1.98 Million	-6,807 Reduced 32.1%	14,397 $3.78 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $91,130 - $102,778	406 Added 1.95%	21,204 $4.78 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $25,608 - $28,498	-111 Reduced 0.53%	20,798 $5.06 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $499,497 - $552,574	2,278 Added 12.23%	20,909 $5.06 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $477,908 - $546,922	2,403 Added 14.81%	18,631 $4.19 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.23 Million - $1.45 Million	-5,814 Reduced 26.38%	16,228 $3.45 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $55,825 - $61,934	239 Added 1.1%	22,042 $5.37 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $1.36 Million - $1.59 Million	6,143 Added 39.23%	21,803 $5.43 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $3.02 Million - $3.59 Million	13,944 Added 812.59%	15,660 $3.6 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $3.05 Million - $3.4 Million	-13,016 Reduced 88.35%	1,716 $436,000
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $162,006 - $198,804	819 Added 5.89%	14,732 $3.47 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $293,770 - $389,620	1,612 Added 13.1%	13,913 $2.82 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $1.42 Million - $1.82 Million	7,486 Added 155.47%	12,301 $2.97 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $77,653 - $93,044	446 Added 10.21%	4,815 $932,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $179,202 - $210,065	-1,075 Reduced 29.15%	2,613 $510,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $292,725 - $343,139	1,756 Added 67.2%	4,369 $809,000
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $194,435 - $219,171	1,075 Added 41.14%	3,688 $716,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $41,032 - $47,897	-230 Reduced 8.09%	2,613 $510,000
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $40,949 - $46,164	221 Added 8.43%	2,843 $566,000
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $97,969 - $110,040	-590 Reduced 18.37%	2,622 $488,000
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $167,905 - $196,218	991 Added 44.62%	3,212 $553,000
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $114,608 - $128,052	-679 Reduced 23.41%	2,221 $394,000
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $485,141 - $553,900	2,900	2,900 $543,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Amgen Inc Transaction History